Haatch Ventures led the pre-seed round to help the learning platform scale its international presence and educator network.
"Pre-seed funding is a hugely exciting time for any start-up – it’s the launchpad from which the future can develop. Having the backing of industry heavyweights like Jason Foster gives me even more conviction in our mission to become the go to educator for data literacy amongst business users. Data-led, data-literate organisations are the future of business, and we are proud to be helping them and their employees get there."
The Manchester customer rewards platform secured backing to build out its workforce following product-market fit.
"DSW have been incredibly generous and supportive with their time and advice since we founded the business. As a result, we have been able to hold off raising until we found our product market fit, and felt that DSW, along with our co-angel investors, were exactly the right combination to execute our growth plans. We’re excited to take Propello forward with their backing, with significant investment already underway in both the platform and team."
QVentures backed the consumer fintech platform to accelerate its go-to-market strategy and expand functionality.
"The investment by QVentures into Taxd means we are able to go to market in a more meaningful way and at an increased pace to help impact the millions of people across the UK who struggle with understanding tax compliance."
The funding round was led by Vanneck EIS to support business growth and product development.
"Making the best decisions about how to use land is vital to addressing the climate and biodiversity crises, but is an increasingly complex challenge. With backing from Vanneck EIS and Octopus Ventures, our new tools will help landowners, investors, and public bodies combine data across science, economics, and regulation to see the potential of land and choose the right way forward."
The Bristol-based biotech start-up has closed its pre-seed round ahead of commercial production and launch.
"There is so much biological information that could enable early intervention for healthcare, but no route to clear access. The menstrual cycle is a non-invasive route to giving our users better health data for better health outcomes,. Many health conditions are difficult for researchers to analyse at the moment because they require invasive testing or regular monitoring which is inconvenient, time-intensive and often uncomfortable. Emm has the potential to do this in a practical, painless way."
